Baicalein Alleviates Neuropathic Pain by Inhibiting Microglial Activation and Inflammation Via the TLR4/NF-κB p65 Pathway
Planta Medica · 01.11.2025 · 91 (13) · 758-770
DOI: 10.1055/a-2665-6684 ↗Kurz gefasst
Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.11.2025. Verfasst von Jieyi Cai und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of Neuroregeneration, Co-innovation Center of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Ne…. Hauptthemen laut MEDLINE: Flavanones, Neuralgia, Toll-Like Receptor 4, Microglia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Clinically, there is a significant unmet need for effective treatments for chronic neuropathic pain. Commonly used drugs, such as opioids, are primarily designed for acute pain management and are associated with substantial adverse effects, including tolerance and addiction. Therefore, the development of safe and effective therapies is of paramount importance. Baicalein (BA), a flavonoid compound extracted from Scutellaria baicalensis, has anti-inflammatory, antibacterial, and anti-proliferative activities against tumor cells and has been used to treat various acute and chronic conditions without notable side effects. In this study, we employed the spared nerve injury (SNI) pain model to investigate the therapeutic efficacy of BA on neuropathic pain and its underlying mechanisms. Results showed that BA effectively alleviated SNI-induced hyperalgesia and the progression of chronic pain in a dose-dependent manner by inhibiting glial cell activation, immune cell infiltration, and inflammatory responses. Additionally, using an in vitro microglial inflammation model, we further confirmed that BA inhibits M1 polarization of microglia and the expression of pro-inflammatory factors by modulating the TLR4/NF-κB p65 signaling pathway. Our results suggest that BA holds promise as a potential therapeutic agent for treating neuropathic pain caused by nerve injury or diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Jiangsu Key Laboratory of Neuroregeneration, Co-innovation Center of Neuroregeneration, Jiangsu Clinical Medicine Center of Tissue Engineering and Nerve Injury Repair, Nantong University, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Cai, J., Luo, L., Yuan, M., Li, H., Chen, L., Peng, Q., Zhu, C., & Gu, Y. (2025). Baicalein Alleviates Neuropathic Pain by Inhibiting Microglial Activation and Inflammation Via the TLR4/NF-κB p65 Pathway. Planta Medica, 91(13), 758-770. https://doi.org/10.1055/a-2665-6684
Vancouver
Cai J, Luo L, Yuan M, Li H, Chen L, Peng Q, et al. Baicalein Alleviates Neuropathic Pain by Inhibiting Microglial Activation and Inflammation Via the TLR4/NF-κB p65 Pathway. Planta Medica. 2025;91(13):758-770. doi:10.1055/a-2665-6684
BibTeX
@article{Cai2025,
author = {Cai, Jieyi and Luo, Ling and Yuan, Min and Li, Hui and Chen, Lü and Peng, Qianqian and Zhu, Changlai and Gu, Yun},
title = {Baicalein Alleviates Neuropathic Pain by Inhibiting Microglial Activation and Inflammation Via the TLR4/NF-κB p65 Pathway},
journal = {Planta Medica},
year = {2025},
volume = {91},
number = {13},
pages = {758--770},
doi = {10.1055/a-2665-6684}
}
EUVIMED